Raymond Debbane - Director at Lexicon Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
LXRX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Raymond Debbane - trading volume in the past year for Lexicon Pharmaceuticals, Inc.

Holdings reported by Raymond Debbane for Lexicon Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5.45M $14.3M $2.62 Apr 28, 2024 By Invus US Partners LLC
Common Stock 1.35M $3.53M $2.62 Apr 28, 2024 Direct
Restricted Stock Units 36.8K $96.4K $2.62 May 13, 2024 Direct Common Stock
Stock Option (Right to Buy) 44.9K May 13, 2024 Direct Common Stock

Transactions reported by Raymond Debbane for Lexicon Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership